PF-08046049 / SGN-BB228

· Seagen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046049 / SGN-BB228, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors [Phase 1]